1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Belgium >
  5. Aratana Therapeutics Acquires Okapi Sciences NV

M&A Deal Summary

Aratana Therapeutics Acquires Okapi Sciences NV

On January 6, 2014, Aratana Therapeutics acquired healthcare services company Okapi Sciences NV

Acquisition Highlights
  • This is Aratana Therapeutics’ 1st transaction in the Healthcare Services sector.
  • This is Aratana Therapeutics’ 1st transaction in Belgium.

M&A Deal Summary
Date 2014-01-06
Target Okapi Sciences NV
Sector Healthcare Services
Buyer(s) Aratana Therapeutics
Deal Type Add-on Acquisition

Target

Okapi Sciences NV

Heverlee, Belgium
Okapi Sciences NV is Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Aratana Therapeutics

Leawood, Kansas, United States
Category Company
Founded 2010
Sector Life Science
Employees83
Revenue 35M USD (2018)
DESCRIPTION

Aratana Therapeutics, Inc. is a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, or pet therapeutics. Aratana Therapeutics, Inc. was formed in 2010 and is headquartered in Leawood, Kansas.

DEAL STATS #
Overall 2 of 2
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
Country: Belgium M&A 1 of 1
Year: 2014 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-14 Vet Therapeutics

Del Mar, California, United States

Vet Therapeutics, Inc. develops and sells antibody-based therapies.

Buy $30M
Mergr

Solution for

Product

Company

Legal